70 related articles for article (PubMed ID: 3348948)
1. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
[TBL] [Abstract][Full Text] [Related]
2. Correction to: "Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With Thyroid Cancer".
J Clin Endocrinol Metab; 2024 Apr; 109(5):e1421. PubMed ID: 38324774
[No Abstract] [Full Text] [Related]
3. Targeting transcriptional regulators for treatment of anaplastic thyroid cancer.
Lee WK; Cheng SY
J Cancer Metastasis Treat; 2021; 7():. PubMed ID: 34761120
[TBL] [Abstract][Full Text] [Related]
4. The utility of some modern techniques in understanding thyroid pathology.
LiVoisi VA
Endocr Pathol; 1990 Jun; 1(2):68-84. PubMed ID: 32138436
[TBL] [Abstract][Full Text] [Related]
5. Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.
Zhu X; Park S; Lee WK; Cheng SY
Endocr Relat Cancer; 2019 Sep; 26(9):739-750. PubMed ID: 31272080
[TBL] [Abstract][Full Text] [Related]
6. New Treatment Options for Metastatic Thyroid Cancer.
Kunadharaju R; Goyal G; Rudraraju A; Silberstein PT
Fed Pract; 2015 Aug; 32(Suppl 7):21S-26S. PubMed ID: 30766126
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors.
Zhu X; Holmsen E; Park S; Willingham MC; Qi J; Cheng SY
Oncotarget; 2018 Oct; 9(83):35408-35421. PubMed ID: 30459933
[TBL] [Abstract][Full Text] [Related]
8. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
Sakr HI; Chute DJ; Nasr C; Sturgis CD
Diagn Pathol; 2017 Oct; 12(1):71. PubMed ID: 28974238
[TBL] [Abstract][Full Text] [Related]
9. Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
Garg M; Kanojia D; Mayakonda A; Ganesan TS; Sadhanandhan B; Suresh S; S S; Nagare RP; Said JW; Doan NB; Ding LW; Baloglu E; Shacham S; Kauffman M; Koeffler HP
Sci Rep; 2017 Aug; 7(1):9749. PubMed ID: 28852098
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
[TBL] [Abstract][Full Text] [Related]
11. Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers.
Tai D; Poon D
J Oncol; 2010; 2010():. PubMed ID: 20862373
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma: targeted therapies and future directions.
Pinchot SN; Kunnimalaiyaan M; Sippel RS; Chen H
J Oncol; 2009; 2009():183031. PubMed ID: 20069043
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells.
Muscella A; Urso L; Calabriso N; Vetrugno C; Rochira A; Storelli C; Marsigliante S
Br J Pharmacol; 2009 Mar; 156(5):751-63. PubMed ID: 19254279
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathobiology of thyroid neoplasms.
Tallini G
Endocr Pathol; 2002; 13(4):271-88. PubMed ID: 12665646
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.
Sarlis NJ
Rev Endocr Metab Disord; 2000 Apr; 1(3):183-96. PubMed ID: 11708296
[No Abstract] [Full Text] [Related]
16. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
Gonsky R; Knauf JA; Elisei R; Wang JW; Su S; Fagin JA
Nucleic Acids Res; 1997 Oct; 25(19):3823-31. PubMed ID: 9380504
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.
Owens LV; Xu L; Dent GA; Yang X; Sturge GC; Craven RJ; Cance WG
Ann Surg Oncol; 1996 Jan; 3(1):100-5. PubMed ID: 8770310
[TBL] [Abstract][Full Text] [Related]
18. c-fos oncogene underexpression in salivary gland tumors as measured by in situ hybridization.
Birek C; Lui E; Dardick I
Am J Pathol; 1993 Mar; 142(3):917-23. PubMed ID: 8456948
[TBL] [Abstract][Full Text] [Related]
19. Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas.
Stringer BM; Rowson JM; Parkar MH; Seid JM; Hearn PR; Wynford-Thomas D; Ingemansson S; Woodhouse N; Goyns MH
Experientia; 1989 Apr; 45(4):372-6. PubMed ID: 2651141
[TBL] [Abstract][Full Text] [Related]
20. Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.
Doucet JP; Squinto SP; Bazan NG
Mol Neurobiol; 1990; 4(1-2):27-55. PubMed ID: 2127531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
